See every side of every news story

Published 20 hours ago • loading... • Updated 20 hours ago

IDEAYA Biosciences Upcoming Investor Relations Events and Updated Darovasertib Topline Results Guidance From Phase 2/3 OptimUM-02 Trial

Summary by Helena Independent Record

SOUTH SAN FRANCISCO, Calif., March 22, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in upcoming investor relations events and provided updated guidance…

3 Articles

3 Articles

Helena Independent Record

Reposted by

MyVillager

IDEAYA Biosciences Upcoming Investor Relations Events and Updated Darovasertib Topline Results Guidance from Phase 2/3 OptimUM-02 Trial

SOUTH SAN FRANCISCO, Calif., March 22, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in upcoming investor relations events and provided updated guidance…

20 hours ago·Helena, United States

Read Full Article

Cancer trial readout nears as IDEAYA targets first-half April lock

Topline analysis comes after a first-half April database lock in first-line metastatic uveal melanoma; management plans a webcast and 30-day replay.

20 hours ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources3

Leaning Left0Leaning Right0Center1Last Updated46 minutes agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Helena Independent Record broke the news in Helena, United States 20 hours ago on Sunday, March 22, 2026.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics